Status:
COMPLETED
Functional Outcome Following Surgical Treatment of Patients With Sternoclavicular Joint Infection
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Sternoclavicular Joint Infection
Eligibility:
All Genders
18+ years
Brief Summary
The Sternoclavicular joints (SCJ) represents an important factor in stability of shoulder joint. Its influence and its function is important for the functionality of the shoulder. SCJ infection is a r...
Eligibility Criteria
Inclusion
- Patient assigned and treated at the Department of Thoracic Surgery, University Hospital Basel (USB)
- At hospital admission diagnosed with clinical characteristics of sternoclavicular joint infection
- Surgical treatment of extended SCJ resection received
- Signed written informed consent according to ICH-GCP regulations prior to initiation of any protocol-specific activities/procedure
- Patients who died will be included if a signed USB general research consent is available
Exclusion
- Isolated sternal or clavicular infection
- Patients received other surgery than extended SCJ resection at USB thoracic surgery
- Inability to follow procedures or insufficient knowledge of language (German/French) or inability to give consent
- Patients who have clearly stated that they would not agree in providing their clinical data for scientific purposes
Key Trial Info
Start Date :
January 2 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 21 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT05234385
Start Date
January 2 2022
End Date
April 21 2022
Last Update
June 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Thoracic Surgery, University Hospital of Basel
Basel, Switzerland, 4031